[{"id":"5d8e201c-02bb-4867-adae-873e70735a40","acronym":"KEYNOTE-B87","url":"https://clinicaltrials.gov/study/NCT04675294","created_at":"2021-01-19T20:45:39.969Z","updated_at":"2025-02-25T16:10:57.319Z","phase":"Phase 2","brief_title":"Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)","source_id_and_acronym":"NCT04675294 - KEYNOTE-B87","lead_sponsor":"ALX Oncology Inc.","biomarkers":" PD-L1","pipe":" | ","alterations":" PD-L1 expression","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Keytruda (pembrolizumab) • evorpacept (ALX148)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 189","initiation":"Initiation: 04/02/2021","start_date":" 04/02/2021","primary_txt":" Primary completion: 12/31/2024","primary_completion_date":" 12/31/2024","study_txt":" Completion: 12/31/2025","study_completion_date":" 12/31/2025","last_update_posted":"2024-07-22"},{"id":"efc815a2-1e81-49d2-a2c9-f52e443dbc76","acronym":"ASPEN-06","url":"https://clinicaltrials.gov/study/NCT05002127","created_at":"2021-08-12T14:54:37.418Z","updated_at":"2024-07-02T16:35:57.123Z","phase":"Phase 2/3","brief_title":"A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)","source_id_and_acronym":"NCT05002127 - ASPEN-06","lead_sponsor":"ALX Oncology Inc.","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 overexpression","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 overexpression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Herceptin (trastuzumab) • paclitaxel • Cyramza (ramucirumab) • evorpacept (ALX148)"],"overall_status":"Recruiting","enrollment":" Enrollment 450","initiation":"Initiation: 01/15/2022","start_date":" 01/15/2022","primary_txt":" Primary completion: 07/01/2026","primary_completion_date":" 07/01/2026","study_txt":" Completion: 08/01/2028","study_completion_date":" 08/01/2028","last_update_posted":"2023-01-24"}]